Cite
HARVARD Citation
Herring, W. et al. (2017). A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-D-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson Disease. Clinical neuropharmacology. 40 (6), p. . [Online].